AFYREN (FR:ALAFY)

:ALAFY

ALAFY

AFYREN

RESEARCH TOOLSreports

Want to see FR:ALAFY full AI Analyst Report?

AFYREN (ALAFY) Price & Analysis

1 Followers

ALAFY Stock Chart & Stats

€2.85

-€0.20(-8.37%)

At close: Jan 09 4:00 PM EST

€2.85

-€0.20(-8.37%)

Day’s Range― - ―

52-Week Range€2.07 - €3.24

Previous CloseN/A

Volume19.43K

Average Volume (3M)10.93K

Market Cap

€97.71M

Enterprise Value€38.70M

Total Cash (Recent Filing)€35.16M

Total Debt (Recent Filing)€2.42M

Price to Earnings (P/E)―

Beta0.13

Next Earnings

Sep 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.53

Shares Outstanding38,852,520

10 Day Avg. Volume15,238

30 Day Avg. Volume10,926

Financial Highlights & Ratios

PEG Ratio-0.12

Price to Book (P/B)1.22

Price to Sales (P/S)33.31

P/FCF Ratio-14.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.41

Revenue Forecast (FY)€2.30M

Bulls Say, Bears Say

Bulls Say

Low Leverage / Strong Balance SheetMaterial debt reduction and a sizeable equity base provide durable financial flexibility. Low leverage lowers interest burden and gives capacity to fund industrial ramp or absorb cash burn, making the balance sheet a structural buffer while operations scale toward break-even.

Diverse End‑market ExposureServing multiple end markets reduces dependence on any single sector and spreads demand risk. Diverse applications for bio‑based acids create cross‑selling and volume opportunities, supporting more stable long‑term demand and resilience to cyclical weakness in any one end market.

Industrial-scale Production / Offtake ModelAn industrialized fermentation footprint and the potential for long‑term offtake contracts create structural revenue visibility once capacity ramps. Contracted sales from industrial assets can convert qualified demand into recurring volumes and improve predictability of future cash flows.

Bears Say

Persistent Revenue DeclineConsecutive double‑digit revenue declines undermine scale economics and limit ability to spread fixed costs across volumes. Sustained top‑line contraction makes margin recovery harder and weakens the case for reaching sustainable profitability without structural commercial progress.

Ongoing Negative Operating Cash FlowChronic negative operating and free cash flow forces reliance on external financing, which can dilute equity or increase leverage. Persistent cash burn constrains reinvestment in capacity or commercial expansion and raises execution risk if capital markets tighten.

Widening Losses And Gross Loss In 2025A swing to a material gross loss and larger net losses signals structural cost or pricing issues. Continued losses erode returns on equity and can deplete the equity buffer over time, increasing the urgency of operational fixes to restore unit economics.

ALAFY FAQ

What was AFYREN’s price range in the past 12 months?

AFYREN lowest stock price was €2.06 and its highest was €3.23 in the past 12 months.

What is AFYREN’s market cap?

AFYREN’s market cap is €97.71M.

When is AFYREN’s upcoming earnings report date?

AFYREN’s upcoming earnings report date is Sep 25, 2026 which is in 105 days.

How were AFYREN’s earnings last quarter?

AFYREN released its earnings results on Mar 31, 2026. The company reported -€0.264 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.264.

Is AFYREN overvalued?

According to Wall Street analysts AFYREN’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AFYREN pay dividends?

AFYREN does not currently pay dividends.

What is AFYREN’s EPS estimate?

AFYREN’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AFYREN have?

AFYREN has 38,852,520 shares outstanding.

What happened to AFYREN’s price movement after its last earnings report?

AFYREN reported an EPS of -€0.264 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.099%.

Which hedge fund is a major shareholder of AFYREN?

Currently, no hedge funds are holding shares in FR:ALAFY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AFYREN

Afyren SAS is a French sustainable chemical firm that manufactures biomolecules by repurposing non-food biological waste. These specialized molecules are utilized across a variety of sectors, including human and animal nutrition, the production of flavors and fragrances, as well as applications in life sciences, material sciences, and lubricants. Their product offerings primarily include a range of biosourced organic acids, specifically acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, and caproic acid. The company was established in 2012 and has its headquarters in Clermont-Ferrand, France.